< Back to all Breaking News
CTIC
8/22/2017 17:08pm
CTI BioPharma: Chief Business Officer Matthew Plunkett resigns
Don't miss out!
We read the Wall Street research, SEC filings and press releases so you don't have to.
Sign up for our 14-day free trial to read this story.